-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune- mediated inflammatory disease with chronic progressive or recurrent processes.
Immune diagnosis
The purpose of this study is to study the cerebrospinal fluid characteristics of continuous CIDP patients observed at the time of diagnosis, including the currently determined laboratory parameters and the less studied OCB, to determine the characteristics that may help diagnosis and/or prognosis.
The purpose of this study is to study the cerebrospinal fluid characteristics of continuous CIDP patients observed at the time of diagnosis, including the currently determined laboratory parameters and the less studied OCB, to determine the characteristics that may help diagnosis and/or prognosis.
At the time of spinal cord puncture, the average duration of CIDP patients was 2.
The correlation between the cerebrospinal fluid protein concentration and QALB in four groups of patients.
Compared with NINPs, the cerebrospinal fluid protein concentration of CIDP patients (35.
The cerebrospinal fluid albumin concentration (p=0.
Compared with NINP, CIDP, GBS and anti-MAG antibody neuropathy have significantly increased CSF protein and blood-spinal nerve root barrier damage.
Intrathecal humoral immune response is rare in CIDP patients.
Leave a message here
